Are there specific MedTech regulations regarding vesting?

No, there are no direct MedTech-specific regulations that mandate or describe vesting schedules. Vesting is primarily a corporate governance and human resources mechanism, governed by contract law and tax regulations, not medical device regulations.

Why would investors care about a MedTech company's vesting schedule?

Investors care about a MedTech company's vesting schedule because it demonstrates founder and key employee commitment and alignment of interests. This commitment is vital for the long-term success of the company, especially given the lengthy development and regulatory approval timelines in the MedTech industry.

All terms

Investment & FinanceStartup Lifecycle

Vesting Schedule

Timeline over which equity is earned by an employee or founder.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

Definition

Vesting is the process by which equity (founder shares, options, RSUs) becomes non-forfeitable over time. The standard schedule is 4 years with a 1-year cliff: 25% vests at the 1-year anniversary, then monthly thereafter. Acceleration clauses can speed vesting on a sale: single-trigger on the sale alone, or double-trigger on a sale plus termination without cause. Founders often agree to re-vest some shares when investors join. In the US, founders with restricted stock often file an 83(b) election within 30 days of grant.

What the regulation says

While not a direct regulatory requirement for MedTech product approval, vesting schedules, particularly for founders and key personnel, are critical for business stability and demonstrating long-term commitment. This stability indirectly supports compliance with quality management system requirements, such as those in 21 CFR Part 820 (Quality System Regulation) and ISO 13485:2016, by ensuring consistent leadership and resource allocation for regulatory affairs and product development. Investors and regulatory bodies assess the overall viability and management structure of a MedTech company, where founder vesting can be a positive indicator of robust governance.

What this means in practice

Founder vesting reassures investors that co-founders are committed; without it, a founder who leaves in year one keeps a huge chunk of the company.

Examples

A MedTech startup implements a 4-year founder vesting schedule with a 1-year cliff to assure Series A investors of the co-founders' long-term dedication to achieving FDA clearance for their novel diagnostic device.
An early-stage MedTech company grants stock options to its lead regulatory affairs specialist with a 3-year vesting period to incentivize their continued employment through the complex EU MDR CE marking process.
During due diligence for acquisition, a large MedTech firm reviews the vesting schedules of the target company's executive team to ensure key talent will remain post-acquisition, critical for the ongoing compliance of their acquired product portfolio.

Common pitfalls

•Assuming vesting schedules are only for founders, neglecting the importance of vesting for other key employees involved in critical regulatory or quality functions.
•Failing to clearly document vesting agreements, potentially leading to disputes that disrupt business operations and regulatory compliance efforts.
•Not considering the impact of accelerated vesting clauses during mergers or acquisitions on intellectual property ownership or continuity of key personnel.
•Overlooking tax implications of different vesting structures for employees, which can affect retention and morale.
•Drafting overly complex vesting conditions that are difficult to administer or understand by the vested parties.

Frequently asked questions

Vesting primarily impacts the MedTech regulatory landscape indirectly by ensuring business stability and continuity of leadership. This stability is crucial for maintaining a robust quality management system and consistently addressing regulatory obligations, as stipulated by regulations like 21 CFR 820 and standards such as ISO 13485.

Grouped by theme

Editor's picks

· Hand-selected related concepts

Investment & Finance

Capitalization Table(Cap Table)

Ledger of all securities issued by a company and who owns them.

Investment & Finance

Employee Option Pool

Shares reserved for issuance to employees as stock options.

Latest in MedTech

Sources

4 sources

Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 3

Link health: 4 verified· last checked 2026-06-20· added official documents checked 2026-11-01

Carta·1PitchBook·1NVCA·1U.S. Securities and Exchange Commission·1

Inline markers like [1] jump to the matching reference above.

My progress

All terms0 / 513

Investment & Finance0 / 47

Saved on this device, and to your account when signed in. View studied terms

Full glossary

Browse all terms A to Z, each with a short definition.

On this term

Category: Investment & Finance
Sources: 4
Updated: 5/5/2026

Compare with another term

Learn in 60 seconds

Timeline over which equity is earned by an employee or founder.

·Founder vesting reassures investors that co-founders are committed; without it, a founder who leaves in year one keeps a huge chunk of the company.
·The standard schedule is 4 years with a 1-year cliff: 25% vests at the 1-year anniversary, then monthly thereafter.
·Acceleration clauses can speed vesting on a sale: single-trigger on the sale alone, or double-trigger on a sale plus termination without cause.

Remember this

Watch out: Assuming vesting schedules are only for founders, neglecting the importance of vesting for other key employees involved in critical regulatory or quality functions.

Related terms

You may also need

Auto-suggested from Investment & Finance and shared keywords.

All Investment & Finance terms